Synopsis : India's organised hospital sector is entering a strong expansion phase, driven by rising healthcare demand, improving insurance penetration and brownfield capacity additions. Antique has initiated coverage on Apollo Hospitals, Medanta, Healthcare Global Enterprises and Max Healthcare, highlighting robust earnings visibility and assigning Buy ratings to most hospital stocks with potential upside of up to 37%.
India's organised hospital industry is poised for sustained growth over the next few years, supported by increasing healthcare demand, higher insurance penetration and an aggressive capacity expansion pipeline. According to brokerage firm Antique, the healthcare delivery market is expected to grow at a compound annual growth rate (CAGR) of 10–12% between FY25 and FY30, reaching nearly ₹12 lakh crore.
The brokerage believes organised private hospitals are well positioned to capture a larger share of this expanding market, with private healthcare providers expected to account for nearly 69% of treatments by FY30, up from 64% in FY20.
Against this backdrop, Antique has initiated coverage on Apollo Hospitals Enterprise, Global Health (Medanta), Healthcare Global Enterprises (HCG) and Max Healthcare Institute, while continuing coverage on Artemis Medicare Services. Apollo Hospitals, Medanta, Healthcare Global Enterprises and Artemis received 'Buy' ratings, whereas Max Healthcare was assigned a 'Hold' rating.
Brownfield expansion to drive growth
Antique expects hospital operators to continue expanding capacity at a healthy pace over the coming years. Hospitals under its coverage have already added nearly 19,000 beds during FY23-FY26, taking their combined capacity beyond 70,000 beds.
By FY30, the brokerage expects total capacity to exceed 1.08 lakh beds, with nearly two-thirds of the expansion coming through brownfield projects. Since brownfield additions typically require lower capital investment and reach optimal occupancy faster than greenfield hospitals, they are expected to generate superior returns on capital.
The brokerage also believes improving operating efficiencies, stronger case mix and healthy balance sheets provide further support to the sector's long-term outlook.
Apollo Hospitals remains a preferred pick
Antique has initiated coverage on Apollo Hospitals with a Buy rating and a target price of ₹9,790, implying an upside of roughly 14%.
The brokerage highlighted Apollo's diversified healthcare ecosystem, which includes hospitals, pharmacies, diagnostics and digital healthcare services. The company currently operates more than 8,100 beds and plans to add around 1,000 additional beds through brownfield expansion and acquisitions over the next few years.
Antique expects Apollo to deliver healthy revenue, EBITDA and profit growth through FY28, supported by improving occupancy levels and higher revenue per patient.
Medanta expected to benefit from capacity additions
Global Health, which operates the Medanta hospital chain, also received a Buy rating with a target price of ₹1,520, representing an upside of approximately 15%.
The brokerage noted that Medanta currently operates six hospitals with nearly 3,700 beds and plans to expand further through brownfield projects. Antique expects the company's Noida hospital to turn profitable during the second half of FY27 while mature hospitals continue improving margins.
Higher occupancy, better operating leverage and expansion of high-value medical services are expected to support earnings growth over the coming years.
Healthcare Global offers the highest upside
Among the hospital stocks covered, Healthcare Global Enterprises (HCG) emerged as Antique's most preferred opportunity.
The brokerage assigned a Buy rating with a target price of ₹840, indicating an upside potential of nearly 37%.
HCG is India's only listed pure-play oncology hospital chain, operating more than 2,600 beds across multiple cities. Antique expects the company to significantly expand its network over the next few years through both brownfield and greenfield projects.
The brokerage believes stronger utilisation levels, an improving patient mix and operational improvements under KKR's ownership could drive substantial earnings growth.
Max Healthcare receives Hold rating
While Antique remains positive on Max Healthcare's long-term business prospects, it has assigned the stock a Hold rating with a target price of ₹1,170, implying a relatively modest upside of around 8%.
The brokerage noted that Max plans to increase its bed capacity by nearly 66% by FY30, with most of the expansion coming through brownfield projects and asset-light management contracts.
However, after the stock's strong rally over recent years, Antique believes much of the near-term growth is already reflected in current valuations.
Artemis continues to remain attractive
Antique has reiterated its Buy rating on Artemis Medicare Services with a target price of ₹340, suggesting an upside of approximately 29%.
The brokerage expects Artemis to more than triple its bed capacity over the next few years through expansion projects in Gurugram, South Delhi and Raipur.
Improving operating leverage and higher occupancy are expected to support robust earnings growth over FY26-FY28.
Positive long-term outlook for hospital sector
According to Antique, concerns about overcapacity in India's hospital sector remain exaggerated despite aggressive expansion plans.
The brokerage expects demand to remain healthy, supported by rising health insurance penetration, government healthcare schemes such as Ayushman Bharat, increasing medical tourism, a growing incidence of chronic diseases and continued market share gains by organised hospital operators.
Supportive policy developments, including revised building norms, updated CGHS reimbursement rates and favourable regulatory changes, are also expected to benefit leading hospital chains.
Conclusion
Antique remains constructive on India's organised hospital sector, citing strong structural demand, faster brownfield expansion, improving profitability and healthy balance sheets across leading operators.
Among its preferred investment ideas, the brokerage favours Apollo Hospitals, Medanta, Healthcare Global Enterprises and Artemis Medicare, while maintaining a Hold rating on Max Healthcare due to valuation concerns despite its strong operational outlook.
Disclaimer : The brokerage ratings, target prices, and financial projections mentioned in this article are based on Antique's institutional research report and are intended solely for informational and educational purposes. They should not be construed as investment advice or a recommendation to buy or sell any security. Investments in hospital and healthcare stocks are subject to market risks, regulatory changes, execution challenges, and sector-specific uncertainties. Investors should conduct their own research and consult a SEBI-registered investment advisor before making any investment decisions.
.jpg)
